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Francis J. Caputo, Jeffrey Jim, MD, Raghuveer Vallabhaneni, MD, Brian
Rubin, MD, Patrick Geraghty, MD, John Curci, MD, Kathleen Raman,
MD, Gregorio Sicard, MD, Luis Sanchez, MD, Section of Vascular Surgery,
Washington University in St. Louis, St. Louis, Mo
Objectives: The purpose of this study is to review a single institution’s
experience of carotid artery angioplasty and stenting (CAS) and re-interven-
tion rates.
Methods: A retrospective analysis of patients that underwent CAS at a
university medical center was performed over an 8-year period from August
2003 to August 2011. Data analysis included patient demographics, opera-
tive details, radiological information and postoperative outcomes.
Results: 317 CAS were performed during the study period. The mean
age of the cohort was 73.6 (range 41-94) years and 205 (64%) procedures
were performed in males. Degree of stenosis was 80% in 263 (83%)
patients and 143 (45%) had symptomatic disease. 145 (46%) of the patients
had a hostile neck (previous neck surgery and/or radiation therapy), 17
(5.3%) had a high anatomic lesion, and the remaining were considered
medically unfit for surgery. 303(96%) patients have 30-day follow-up with a
total mean follow-up of 21.8 (range 1-85) months. Restenosis of80% was
found in 21 patients (6.6%) with a mean time to restenosis of 14.7 months.
For patients with restenosis, 3 patients had an occlusion of their stents and
13 (61.9%) patients had a re-intervention of either balloon angioplasty or
CAS and the remaining were observed. Of those patients who underwent
re-intervention, 3 (14%) were due to symptomatic disease and the remaining
were treated at the physician’s discretion. Patients with a hostile neck had a
significantly higher restenosis rate of 12.5% versus those with de-novo
Fig 2.
Fig 3.lesions had a restenosis rate of 3.6% (p0.05). For the entire cohort, 30-day
rates of stroke, myocardial infarction (MI) and death was 1.6%, 1.3% and
t
c.9%, respectively. The combined 30-day stroke/death rate was 3.5%. At a
ean follow-up of 21.8 (range 1-85) months the stroke and mortality rates
ere 2.5% and 14.5%.
Conclusions: CAS can be performed safely with good 30-day out-
omes and a low incidence of stroke at two years. Restenosis rates are
ignificantly higher in patients with “hostile” necks. However, these were
ften amenable to endovascular re-intervention.
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ominal Aortic Aneurysm
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Objective:Management of type 2 endoleak (T2E) following endovas-
ular abdominal aortic aneurysm repair (EVAR) has evolved over the last
ecade to observation and selective intervention. The aim of this study was
o evaluate long-term outcomes in patients with T2E.
Methods: Data from 779 patients who underwent EVAR over a
0-year period from 1999 to 2009 were analyzed for incidence and long-
erm outcomes of T2E. Clinical records and CT angiography studies per-
ormed within 6 months following EVAR and at least annually thereafter
ere assessed.
Results: 159 patients (20.4%) were identified with a T2E over a mean
ollow-up of 37.3 months (range: 6 to 121 months). Patients were classified
ccording to the time of occurrence of their T2E post-EVAR: early (0-6
onths with resolution thereafter. n38, 23.9%), late (first noticed 24
onths, n20, 12.6%) and persistent (present at all times, n101, 63.5%).
he average sac size change was: early1.36  11.15mm, persistent0.16
6.66mm and late0.65  6.43mm. There were no aneurysm related
eaths; 73 patients died from unrelated causes during follow-up. Sixty-three
atients underwent endovascular intervention to treat the T2E: 11, 43 and
in the early, persistent and late groups, respectively. Prior to 2005
ntervention for T2E was aggressive, but subsequent to this an observational
pproach was adopted. Mean sac diameter change in patients undergoing
ntervention prior to 2005 was -0.19  9.14mm and subsequent to 2005
as 0.69  7.51mm. Fifteen (24%) patients underwent 1 intervention.
here were two complications: one sigmoid ischemia requiring colectomy
nd one psoas infarction. Using aWeibull analysis, the estimated survival free
f endoleak after an intervention at 1 and 2 years was 40% and 30%
espectively. However, further sac growth at 1 and 2 years occurred only in
5% and 42% respectively. Two patients underwent conversion to open
epair, one for contained rupture.
Conclusions: In-spite of adopting an observational policy towards
2E nearly half of all patients with persistent and late onset endoleaks
equired intervention for enlarging sac size over time. Although success at
ontrolling the endoleak was low with endovascular intervention, subse-
uent sac growth was halted in the majority. Close surveillance of patients
ith T2E is still recommended.
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Introduction: It has been hypothesized that the hypercoagulable state
ssociated with malignancy results in decreased patency after peripheral
rterial endovascular intervention. We aimed to determine the long-term
utcomes of cancer patients undergoing percutaneous interventions for
AD.
Methods:A prospective database identified patients with a diagnosis of
ancer who subsequently underwent percutaneous infrainguinal arterial
nterventions from 2004-2009. Patient demographics, medical co-morbid-
ties, procedural details, and outcomes were reviewed by a dedicated research
eam. Patients were followed clinically and by duplex ultrasound at 6 month
ntervals. Kaplan-Meier survival analysis and Cox proportional hazards
odel were performed.
Results: Of 1220 patients undergoing peripheral endovascular inter-
ention, 174 (14%) were identified as having a diagnosis of malignancy.
hese patients were compared to controls with regard to smoking history
51 %vs.58%;p.012), end stage renal disease(5%vs 10%;p0.016), and
iabetes(49%vs 59%;p0.016). Primary patency rates for the cancer patients
nd controls were compared at 3 years post-intervention (50.5%vs.41.9%;
0.007). To determine if cancer is an independent risk factor for poor
atency, a multiple regression analysis was performed, controlling for diabe-
es, renal failure, smoking history, and indication for intervention (claudica-
ion or critical limb ischemia) to compare patency rates in cancer patients to
ontrols (p.215). (Table 1)
